254 studies found for:    E3A06
Show Display Options
Rank Status Study
1 Recruiting Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Conditions: Light Chain Deposition Disease;   Smoldering Plasma Cell Myeloma
Interventions: Drug: Lenalidomide;   Other: Clinical Observation;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment
2 Completed
Has Results
Enhancing Equitable and Effective (E-3) Post Traumatic Stress Disorder (PTSD) Disability Assessment
Condition: Post-Traumatic Stress Disorder
Interventions: Behavioral: CAPS/WHODAS;   Behavioral: Nonstructured Interview
3 Completed
Has Results
Special Investigation (Follow up Survey of the Study of Adalimumab (D2E7)for Prevention of Joint Destruction in Patients With Rheumatoid Arthritis in Japan (M06-859(NCT00870467)
Condition: Rheumatoid Arthritis
4 Completed A Pharmacokinetic Evaluation of Bioidentical Compounded Estrogen Cream and Natural Progesterone
Condition: Menopause
Interventions: Drug: bioidentical hormone (Biest);   Drug: bioidentical hormone (Vivelle-Dot)
5 Unknown  Study of DNA Samples From Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Intervention: Genetic: polymorphism analysis
6 Recruiting Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS
Condition: HIV/AIDS
Interventions: Biological: DNA;   Biological: AIDSVAX B/E
7 Completed Special Investigation in Patients With Rheumatoid Arthritis (HOPE3 Study Follow up Survey (P12-069))
Condition: Rheumatoid Arthritis
8 Completed Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
Conditions: Cervical Cancer;   Precancerous Condition
Intervention: Biological: pNGVL4a-Sig/E7(detox)/HSP70 DNA vaccine
9 Terminated 3-Dimensional Conformal Radiation Therapy or Internal Radiation Therapy After Breast-Conserving Surgery in Treating Women With Stage I or Stage II Breast Cancer
Condition: Breast Cancer
Interventions: Radiation: 3-dimensional conformal radiation therapy;   Radiation: brachytherapy
10 Completed Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury
Conditions: Myocardial Ischemia;   Coronary Disease;   Myocardial Infarction
Interventions: Drug: FX06;   Procedure: Percutaneous coronary intervention
11 Terminated Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer
Conditions: Non-melanomatous Skin Cancer;   Pancreatic Cancer;   Small Intestine Cancer;   Testicular Germ Cell Tumor
Interventions: Genetic: in situ hybridization;   Genetic: protein expression analysis;   Other: immunologic technique
12 Terminated Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Polyphenon E +Tarceva (Erlotinib)
13 Active, not recruiting Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
Condition: Crohn's Disease
Intervention: Biological: Adalimumab
14 Terminated Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer
Conditions: Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer
Interventions: Dietary Supplement: defined green tea catechin extract;   Drug: placebo;   Procedure: therapeutic conventional surgery;   Other: pharmacological study;   Other: laboratory biomarker analysis
15 Completed
Has Results
Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents
Condition: Influenza
Interventions: Biological: Cell culture-derived influenza subunit vaccine (cTIV);   Biological: Egg derived influenza subunit vaccine (eTIV_f)
16 Active, not recruiting A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: bevacizumab;   Drug: docetaxel;   Drug: doxorubicin;   Drug: cyclophosphamide;   Drug: pegfilgrastim
17 Recruiting A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)
Condition: Follicular Lymphoma
Interventions: Biological: PF-05280586;   Biological: MabThera®
18 Completed
Has Results
A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Biological: Double-blind adalimumab;   Drug: Double-blind Placebo;   Biological: Open-label Adalimumab;   Biological: Open-labelAdalimumabRescue
19 Completed
Has Results
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking Either WHO Step I or Step II Analgesics or no Regular Analgesic
Conditions: Chronic Pain;   Osteoarthritis
Intervention: Drug: Tapentadol
20 Completed E-MOSAIC Electronic Tool to Monitor Symptoms
Condition: Cancer

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years